ABSTRACT Every bulky lesion in DNA can potentially inhibit the Taq DNA polymerase and thereby decrease the amplification produced in the polymerase chain reaction. We investigated the feasibility of using this inhibition to quantify DNA lesions produced by the anticancer drug cisplatin. Products were detected by electrophoresis followed by ethidium bromide staining. 
INTRODUCTION
Studies correlating DNA damage with cytotoxicity have generally assumed homogeneity in the distribution of damage. Various studies on carcinogens, however, have shown that DNA damage can occur in a non-random manner (1) . Furthermore, DNA repair can also vary throughout the genome. It has been shown that actively transcribed genes can be repaired more efficiently than untranscribed regions (1) . This is particularly true for UV-induced DNA damage. The formation of pyrimidine dimers in specific genes can be measured using the dimer-specific enzyme T4 endonuclease V. This enzyme introduces a single strand break at the site of the damage. DNA from UV-irradiated cells is digested with an appropriate restriction endonuclease, cleaved with T4 endonuclease V, denatured and electrophoresed. Southern hybridization is used to identify the amount of full length single-strand DNA of any gene of interest: the intensity of hybridization reflects the amount of undamaged DNA. To measure gene specific damage induced by other agents, particularly those that produce bulky lesions in DNA, it is necessary to use the E. coli uvrABC excinuclease complex that recognizes and incises at a broad spectrum of DNA lesions (2) .
Cisplatin is a major anticancer drug that elicits its cytotoxicity as a consequence of producing bifunctional lesions in DNA; these lesions are predominantly DNA intrastrand cross-links but DNA interstrand cross-links are also formed (3) . We have previously established that mouse L1210 cells resistant to cisplatin exhibit enhanced DNA repair (4, 5) . Enhanced DNA repair has subsequently been observed in human ovarian carcinoma cells (6) . Recent work has also shown that cisplatin lesions may be repaired preferentially from transcribed regions of the genome (7) , and furthermore, that this may contribute to the altered repair observed in resistant cells (8) . The detection of cisplatin lesions in specific genes has required the use of the uvrABC excinuclease complex although it appears to cleave at less than 30% of the cisplatin lesions (7) . The polymerase chain reaction can be used as an alternative approach to measuring gene-specific damage and has the advantage of not requiring specific damagerecognition endonucleases. To date, this method has only been reported for the measurment of UV-induced lesions (9), but the sensitivity was far inferior to that for the T4 endonuclease Vdependent method. Here we describe the development of this method to detect cisplatin lesions in DNA and demonstrate that it has at least as good sensitivity as the uvrABC excinucleasedependent method. The advantage of this method is that it requires no specific enzymes to recognize and cleave DNA adducts, and therefore will facilitate studies in many different laboratories.
METHODS

Cell culture
Chinese hamster ovary (CHO) cells were grown as described previously (10) . Cells (107) were plated in 160 mm culture dishes. The following day the media was replaced with serumfree medium containing the required concentration of cisplatin.
The cells were incubated at 37°C for 2 h, harvested by scraping and washed twice with phosphate buffered saline. DNA was purified by cell lysis, protease digestion and phenol extraction (11) . After ethanol precipitation, the purified DNA was redissolved in 10 mM tris/1 mM EDTA and digested overnight with Kpn I (BRL Life Technologies) in the suppliers recommended buffer. This digestion reduces the viscosity of the DNA without cleaving the sequences to be amplified. DNA was reprecipitated with ethanol, dissolved in water and the concentration was determined by fluorimetry using Hoechst 33258 dye (12) . The samples were diluted to 25 ,ug/ml and the concentration was confirmed by fluorimetry. The level of DNA platination was also determined by flameless atomic absorption spectrometry.
In vitro platination of DNA Undamaged DNA was purified from CHO cells and then platinated to defined levels as previously described (13) .
Polymerase chain reaction
The following primers derived from the hamster adenine phosphoribosyltransferase gene were synthesized. The numbers refer to the position in the published sequence (14 (Fig. 2) . Amplification of the 750 bp fragment was barely visible when platinated to 10 Pt/10 kb, whereas amplification of the 150 bp fragment was only slightly reduced at 40 Pt/10
kb. These results demonstrate that the sensitivity for detection of DNA damage is related to the size of the fragment amplified. This method was applied to CHO cells that had been incubated with 0-125 ,tM cisplatin to determine whether the DNA damage was detectable. The ethidium bromide staining showed a significant reduction in amplification of the 2 kbp fragment at and above 75 yM cisplatin (Fig. 4) . A (Fig. 4) In this experiment the same molar ratio of cisplatin to DNA was used, but higher concentrations of both were used compared to the previous experiment. After PCR, it was evident that a much greater inhibition of amplification was obtained indicating much higher levels of platination of the 150 bp fragment (Fig. 5 ). These results demonstrate that at low concentrations of DNA and cisplatin, other minor components of an incubation can compete with DNA for reaction with cisplatin. Therefore PCR is a useful method to assure damage at low concentrations of DNA and cisplatin.
DISCUSSION
We have demonstrated in this paper that PCR can be used to quantify damage induced in DNA by cisplatin. Using DNA with defined levels of damage, inhibition of PCR was observed to an extent that suggested the Taq DNA polymerase was inhibited at every Pt lesion. About 65% of the lesions in DNA are intrastrand cross-links at the sequence d(GpG), while 25% occurs at d(ApG) and about 6% at dGpNpG) (where N is any nucleotide) (3). Only about 1% of the lesions represent DNA interstrand cross-linksand are therefore too rare to contribute to the observed results. It is feasible that a low percentage of lesions could be by-passed by the polymerase but this would not be detected by this assay and would not contribute significantly to quantitation of the lesions in DNA. In cells that were platinated in culture, inhibition of PCR was also observed and this agreed closely with the amount of DNA damage measured directly by atomic absorption. Therefore, under these conditions, the only detectable blocks to PCR were the Pt lesions. The sensitivity for detection of DNA damage is dependent upon the size of the target sequence. At any level of platination, there is a greater probability that an adduct lies within a 2 kbp region than within a 150 bp sequence. Therefore, amplification of the longer fragment is expected to be more inhibited than the shorter fragment or, to express it another way, higher amounts of damage must be introduced into a short fragment to produce an equivalent inhibition of amplification. This agrees very well with the experimental observations. It should be possible to increase the sensitivity of the assay by increasing the size of the fragment to be amplified. However, the longest sequence that we are aware of that has been successfully amplified is 10.2 kbp but the efficiency of amplification decreased markedly with increasing size of fragment (15) . This suggests that little increase in sensitivity can be obtained in practical terms by increasing the target size much further than the 2 kbp used here.
There is always concern for potential variations in the efficiency of amplification between various DNA preparations. Such variations may arise from contamination in samples, quantitation of DNA, or fluctuations in the amplification reaction. This can be accounted for in the current protocol by amplification of a 150 bp fragment. This acts effectively as a control because it will have insufficient damage to inhibit PCR. In the current experiments, no variation in amplification of the 150 bp fragment was observed in DNA purified from cells. However, should variations be observed, it would be easy to normalize the amplification of the large fragment to that observed for the small fragment. Furthermore, with appropriate selection of primers, it would be feasible to amplify fragments of different sizes and from different genes in a single reaction. This was not possible in the current experiments because the smaller fragments were contained within the larger fragments, and therefore would have been amplified from the product of the other amplifications.
In these experiments, we were able to detect damage in cells incubated with 75 ,uM cisplatin. The LCgo for a 2 h incubation of these cells in cisplatin is 30 yM (10) so the cells had to be incubated with greater than a 99% lethal concentration before lesions were detectable. Using the uvrABC complex to detect cisplatin lesions in specific genes of CHO cells, a 1 h incubation with 100-300 /tM cisplatin was used (7) . Therefore the sensitivity of the current assay appears to be as good as the previously available method. In the experiments with uvrABC, the target gene was up to 23 kbp, hence a greater sensitivity would be expected. The fact that greater sensitivity was not seen can in part be attributed to the endonuclease complex cleaving at only 30% of the lesions (7), whereas the Taq DNA polymerase appears to stop at every lesion.
The original experiments on gene-specific damage were performed with UV-damaged DNA. Incisions were made at the site of pyrimidine dimers using T4 endonuclease V, then the DNA was denatured and analyzed by Southern hybridization. In those experiments, DNA damage was detected at 10-20 J/m2 while the LCgo value was 15 J/m2 (16) . Hence, the lesions were detectable at somewhat less toxic concentrations than for cisplatin. It can be reasoned that it takes less cisplatin lesions than UVinduced dimers to kill cells.
A recent paper has also demonstrated the use of PCR to detect damage in specific genes, but in this case they studied UV-induced DNA damage (9) . A 50% inhibition of PCR was observed in cells irradiated with 6 kJ/m2. Surprisingly, this inhibition was independent of the size of the sequence amplified; in their case the sequences were 147-440 bp. The radiation required to bring about this inhibition of PCR was 600 fold higher than required to detect gene-specific damage using T4 endonuclease V (16). This is in part due to the smaller size of the target analyzed, 440 bp rather than 9-23 kbp used in the endonuclease studies. It may also suggest that the Taq DNA polymerase does not stop at every pyrimidine dimer. It was previously demonstrated that UV-irradiation of CHO cells with 10 J/m2 produced one endonuclease-sensitive site/20 kb of the dhfr gene (17) . This is in close agreement with the calculated value of 0.8 endonuclease sensitive sites/108 daltons/J/m2 for the overall CHO genome (18) . This calculates to 1 pyrimidine dimer/8 bases at 24 kJ/m2. This is considerably more damage than the 2-3 pyrimidine dimers per 440 bp fragment calculated by Govan et al for a radiation dose of 24 kJ/m2 (9) . A likely explanation for these discrepancies is that the previous report started with 100 ng DNA and used 40 cycles of PCR which should be far beyond the exponential phase of amplification.
Most of the studies on damage in specific genes are designed to investigate the potentially different rates of DNA repair in these genes. The toxicity of the agent under investigation is therefore of particular concern. All of the methods used to date require that toxic conditions be used. For UV-unduced DNA damage, it is necessary to use -90% lethal irradiation, and for cisplatin, it requires -99% lethal concentration. It is feasible that these conditions could considerably alter the kinetics of repair or even the genomic domains that are repaired. The different toxicities required for each agent may explain why gene-specific or strandspecific DNA repair is not observed for all agents. Perhaps more significant is the concern that the repair that is observed is occurring in cells that are destined to die. Although the cell membranes may still be intact as assayed by trypan blue exclusion, it is known that genomic DNA is digested by endonucleases in dying cells long before any indication of changes in membrane integrity (19, 20) . For example, in experiments not shown, the CHO cells incubated with cisplatin above have been further incubated for 24 h in the absence of drug to permit DNA repair. At drug concentrations above 25 ,tM, the genomic DNA had been cleaved to fragments of 180 bp or oligomers of this length. These fragments are characteristic of the internucleosomal digestion of DNA associated with cell death by apoptosis. Little attention has been given to this concern. Presumably, the degraded DNA was excluded from the analysis. In ongoing studies, we have found that murine leukemia L1210 cells are more resistant to endonuclease digestion associated with cell death, and that gene-specific damage and repair can be assessed with this PCR-based method.
In summary, the PCR-based method for measuring genespecific damage appears to be as sensitive as other available techniques. Its major advantage is that it requires no specific enzymes to recognize and cleave DNA adducts. The uvrABC excinuclease complex used for such studies is not generally available and the current method will therefore provide a very convenient alternative method.
